Antibody Humanization Market Industry Trends and Future Prospects 2035
As therapeutic biologics evolve beyond conventional IgG monoclonal formats, protein engineering protocols must adapt to increasingly complex molecular architectures. Biopharmaceutical pipelines are rapidly expanding to include bispecific antibodies, antibody-drug conjugates (ADCs), single-domain antibodies (nanobodies), and engineered Fc-fusion proteins. These novel constructs present unique...
0 Comments 0 Shares 64 Views 0 Reviews